Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder - Trial 2008-002063-13
Access comprehensive clinical trial information for 2008-002063-13 through Pure Global AI's free database. This phase not specified trial is sponsored by Pfizer Inc and is currently status unknown. The study focuses on Major Depressive Disorder.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2008-002063-13
Trial Details
EU Clinical Trials Register • 2008-002063-13
Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Study Focus
Sponsor & Location
Pfizer Inc
Pfizer, Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Change from Baseline to Week 8 visit in the CDRS-R total score
ICD-10 Classifications
Recurrent depressive disorder
Recurrent depressive disorder, unspecified
Depressive conduct disorder
Other recurrent depressive disorders
Recurrent depressive disorder, current episode moderate
Data Source
EU Clinical Trials Register
2008-002063-13
Non-Device Trial